Retrospective study investigating the safety and efficacy of canakinumab in treatment of Familial Mediterranean Fever (FMF) in adults and adolescents

Trial Profile

Retrospective study investigating the safety and efficacy of canakinumab in treatment of Familial Mediterranean Fever (FMF) in adults and adolescents

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Canakinumab (Primary) ; Anakinra; Colchicine
  • Indications Familial Mediterranean fever
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Jan 2017 Results assessing efficacy and safety of Canakinumab published in The Journal of Rheumatology (2017).
    • 11 Jun 2016 Results presented at the 17th Annual Congress of the European League Against Rheumatism
    • 09 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top